Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
This issue of the journal features a Series of three papers on artificial intelligence (AI) in infectious diseases. The Series, led by Anna Odone (University of Pavia, Italy) and published online in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results